title: Okadaic acid promotes angiogenesis via activation of hypoxia-inducible factor-1.
abstract: Okadaic acid, a potent tumor promoter and an inhibitor of protein phosphatase 1 and 2A, has also been characterized as an angiogenic inducer in the chorioallantoic membrane of the chick embryo. To elucidate the roles of okadaic acid on angiogenic processes, we conducted in vitro angiogenesis assays. In this study, we report that okadaic acid potently stimulated tube formation, migration, and invasion of human umbilical vein endothelial cells. Moreover, okadaic acid elevated the activities of hypoxia-inducible factor-1 (HIF-1), which is closely related with the expression of vascular endothelial growth factor. Exposure to okadaic acid markedly increased the HIF-1alpha protein level through up-regulation of translation via activation of Akt and mTOR pathway. Taken together, these results demonstrated that okadaic acid promotes angiogenesis through stimulation of Akt mediated HIF-1alpha translation.
authors.affiliation: Department of Anatomy and Neurobiology, Biomedical Science Institute, School of Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea.
authors.forename: Young-Sun
authors.initials: YS
authors.lastname: Kim
authors.forename: Kook-Hee
authors.initials: KH
authors.lastname: Ahn
authors.forename: Seon-Ye
authors.initials: SY
authors.lastname: Kim
authors.forename: Joo-Won
authors.initials: JW
authors.lastname: Jeong
mesh_terms: D043925:Angiogenesis Inducing Agents / Q000494:pharmacology*; D015153:Blotting, Western; D002273:Carcinogens / Q000494:pharmacology; D002465:Cell Movement / Q000187:drug effects; D042783:Endothelial Cells / Q000187:drug effects; D005455:Fluorescent Antibody Technique; D005786:Gene Expression Regulation / Q000187:drug effects*; D006367:HeLa Cells; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000187:drug effects* / Q000378:metabolism; D007150:Immunohistochemistry; D018919:Neovascularization, Physiologic / Q000187:drug effects / Q000502:physiology*; D019319:Okadaic Acid / Q000494:pharmacology*; D014176:Protein Biosynthesis; D051057:Proto-Oncogene Proteins c-akt / Q000096:biosynthesis / Q000187:drug effects; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014162:Transfection; D014471:Umbilical Veins / Q000187:drug effects; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis / Q000187:drug effects
chemical_list: D043925:Angiogenesis Inducing Agents; D002273:Carcinogens; C497442:HIF1A protein, human; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D042461:Vascular Endothelial Growth Factor A; D019319:Okadaic Acid; D051057:Proto-Oncogene Proteins c-akt